Regulator to decide on Pfizer/BioNTech COVID-19 jab first
FRANKFURT AM MAIN — Europe's medicines regulator said Tuesday it would decide by December 29 whether to grant emergency approval to a COVID-19 vaccine developed by Germany's BioNTech and its US partner Pfizer, ahead of a rival treatment from Moderna. The European Medicines Agency (EMA) confirmed th»»»
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.Comment